TREDOL

This brand name is authorized in Cyprus, Hong Kong, Malta

Active ingredients

The drug TREDOL contains one active pharmaceutical ingredient (API):

1 Atenolol UNII 50VV3VW0TI - ATENOLOL

Atenolol is a beta-blocker which is beta1-selective, (i.e. acts preferentially on beta1-adrenergic receptors in the heart). Atenolol is without intrinsic sympathomimetic and membrane-stabilising activities and as with other beta-blockers, has negative inotropic effects. Read about Atenolol

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
TREDOL Tablet	Υπουργείο Υγείας (CY)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
C07AB03	Atenolol	C Cardiovascular system → C07 Beta blocking agents → C07A Beta blocking agents → C07AB Beta blocking agents, selective
Discover more medicines within C07AB03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: HK	Department of Health Drug Office	Identifier(s): 41624, 41625
Country: MT	Medicines Authority	Identifier(s): MA115/00201, MA115/00202, MA115/00203